Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Pediatrix Medical Group Inc (NYSE: MD) was $16.04 for the day, down -0.25% from the previous closing price of $16.08. In other words, the price has decreased by -$0.25 from its previous closing price. On the day, 0.65 million shares were traded. MD stock price reached its highest trading level at $16.2689 during the session, while it also had its lowest trading level at $15.86.
Ratios:
Our analysis of MD’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.25 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.96. For the most recent quarter (mrq), Quick Ratio is recorded 1.42 and its Current Ratio is at 1.42. In the meantime, Its Debt-to-Equity ratio is 0.93 whereas as Long-Term Debt/Eq ratio is at 0.88.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on September 26, 2024, Upgraded its rating to Buy and sets its target price to $14 from $8 previously.
On June 07, 2024, Deutsche Bank Upgraded its rating to Hold which previously was Sell but kept the price unchanged to $8.
On September 27, 2021, SVB Leerink started tracking the stock assigning a Mkt Perform rating and target price of $29.SVB Leerink initiated its Mkt Perform rating on September 27, 2021, with a $29 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 04 ’24 when Richards C Marc bought 118,291 shares for $14.98 per share.
Swift James D sold 11,100 shares of MD for $119,769 on Aug 30 ’24. The Chief Executive Officer now owns 170,001 shares after completing the transaction at $10.79 per share. On Aug 30 ’24, another insider, Swift James D, who serves as the Officer of the company, bought 11,100 shares for $10.79 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MD now has a Market Capitalization of 1380959104 and an Enterprise Value of 1818956288. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.69 while its Price-to-Book (P/B) ratio in mrq is 1.88. Its current Enterprise Value per Revenue stands at 0.906 whereas that against EBITDA is 9.139.
Stock Price History:
Over the past 52 weeks, MD has reached a high of $16.41, while it has fallen to a 52-week low of $6.62. The 50-Day Moving Average of the stock is 33.77%, while the 200-Day Moving Average is calculated to be 68.73%.
Shares Statistics:
MD traded an average of 658.61K shares per day over the past three months and 924940 shares per day over the past ten days. A total of 85.88M shares are outstanding, with a floating share count of 84.56M. Insiders hold about 1.54% of the company’s shares, while institutions hold 101.89% stake in the company. Shares short for MD as of 1728950400 were 4385647 with a Short Ratio of 6.66, compared to 1726185600 on 4792745. Therefore, it implies a Short% of Shares Outstanding of 4385647 and a Short% of Float of 7.199999999999999.
